Related Experiment Video
Updated: Aug 14, 2026

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk
Published on: July 27, 2022
Kyotorphin has a novel action on rat cardiac muscle
Yue Li1, Yumiko Saito, Masahiko Suzuki
1Department of Pharmacology, Saitama Medical School, Moroyama 38, Iruma-gun, Saitama 350-0495, Japan.
Abstract:
Several endogenous peptides for G-protein-coupled receptors have been found to play physiological roles in muscle contraction in addition to their well-demonstrated actions in other tissues. To further identify such peptides, we screened over 400 peptides using an isometric tension assay of rat papillary muscle. Here, we report that kyotorphin, which is known as an analgesic dipeptide, has a cardiac effect. Although kyotorphin had no effect on the twitch tension itself, it inhibited beta-adrenergic agonist isoprenaline-induced increases in twitch tension in a dose-dependent manner. Leu-Arg, a selective antagonist of kyotorphin, reversed this inhibitory effect. The inhibitory effect was also reversed by naloxone, an opioid receptor antagonist. These results suggest that kyotorphin may release opioid peptides from rat cardiac muscle and have an indirect regulatory role in beta-adrenergic action through cross-talk with opioid receptors.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Antihypertensive Drugs: Action of Calcium Channel Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
